FITC Anti-Human CD57 Antibody[HNK-1]

The FITC Anti-Human CD57 Antibody [HNK-1] is a highly specialized and meticulously developed product designed for the precise detection and analysis of CD57 antigen expression in human samples. This antibody, conjugated with Fluorescein Isothiocyanate (FITC), offers exceptional sensitivity and specificity, making it an invaluable tool for researchers and clinicians alike.

CD57, also known as HNK-1, is a glycoprotein expressed on the surface of natural killer cells, T cells, and subsets of B cells. It plays a crucial role in immune response regulation and has been implicated in various diseases, including autoimmune disorders, infectious diseases, and cancer. The ability to accurately assess CD57 expression is therefore of paramount importance in understanding the underlying mechanisms of these conditions.

The FITC Anti-Human CD57 Antibody [HNK-1] has been meticulously validated and optimized to ensure optimal performance across a wide range of applications, including flow cytometry, immunohistochemistry, and immunofluorescence. Its exceptional specificity guarantees minimal cross-reactivity with other antigens, ensuring reliable and accurate results.

This antibody is supplied in a convenient and ready-to-use format, eliminating the need for time-consuming and error-prone conjugation procedures. Its high affinity and low background staining enable precise and reproducible detection of CD57 expression, even in samples with low antigen density.

Furthermore, the FITC conjugation provides excellent fluorescence intensity, allowing for easy visualization and quantification of CD57-positive cells. This feature is particularly advantageous in flow cytometry experiments, where the identification and enumeration of specific cell populations are crucial.

In summary, the FITC Anti-Human CD57 Antibody [HNK-1] is a meticulously developed and highly reliable tool for the detection and analysis of CD57 antigen expression. Its exceptional sensitivity, specificity, and convenience make it an indispensable asset for researchers and clinicians investigating the role of CD57 in various diseases and immune responses.